31 studies found for:    nsabp p-5
Show Display Options
Rank Status Study
1 Active, not recruiting Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer;   Precancerous Condition
Interventions: Drug: rosuvastatin;   Other: placebo
2 Recruiting Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia
Condition: Intraepithelial Carcinoma
Interventions: Drug: Tamoxifen;   Drug: placebo
3 Completed Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Condition: Breast Cancer
Interventions: Drug: Raloxifene;   Drug: Tamoxifen
4 Terminated BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Trastuzumab;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: 5-Fluorouracil;   Drug: Epirubicin;   Drug: Cyclophosphamide
5 Active, not recruiting Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: tamoxifen citrate;   Radiation: Radiation Therapy
6 Completed Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: Placebo
7 Active, not recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Letrozole;   Other: Placebo
8 Active, not recruiting Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: adriamycin;   Drug: epirubicin;   Drug: fluorouracil
9 Active, not recruiting Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: 3-dimensional conformal accelerated partial breast irradiation;   Radiation: brachytherapy;   Radiation: whole breast irradiation;   Radiation: MammoSite or other single-entry intracavitary device
10 Completed Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
Conditions: Colorectal Cancer;   Fatigue;   Long-term Effects Secondary to Cancer Therapy in Adults;   Pain;   Psychosocial Effects of Cancer and Its Treatment
Intervention: Other: Telephone interview
11 Completed Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
Condition: Breast Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Doxorubicin;   Drug: Tamoxifen
12 Active, not recruiting Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Conditions: Breast Cancer;   Depression;   Fatigue;   Sleep Disorders
Interventions: Drug: Metformin;   Drug: Placebo
13 Completed Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
Conditions: Breast Cancer;   Perioperative/Postoperative Complications
Interventions: Other: questionnaire administration;   Procedure: conventional surgery
14 Active, not recruiting Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: radiation therapy
15 Completed Breast Cancer Treated by Neoadjuvant Chemotherapy
Condition: Individualized Chemotherapy
Interventions: Drug: Taxotere;   Drug: 5-Fluorouracil;   Drug: Epirubicin;   Drug: Cyclophosphamide
16 Completed
Has Results
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin
17 Completed Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: Taxotere;   Drug: Adriamycin
18 Unknown  Breast Cancer Registry in Thailand
Conditions: Conditions or Focus of Study: *FDAAA;   (Enter 1 to 5 Items)
Intervention:
19 Active, not recruiting Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Condition: Breast Cancer
Interventions: Biological: herceptin;   Drug: adriamycin;   Drug: cyclophosphamide;   Drug: taxol
20 Active, not recruiting Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride (Adriamycin);   Drug: gemcitabine hydrochloride

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years